Hideki Garren, Chief Medical Officer at PROTHENA CORP PUBLIC LTD CO (PRTA), sold 2,000 shares at $55.48 ($111K) on 2023-09-13, disclosed to the SEC on 2023-09-13.
Scheduled sale ($111k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PRTA | SELL | 2023-06-16 | $542K | — | Filing → |
| PRTA | SELL | 2023-06-14 | $607K | — | Filing → |
| PRTA | SELL | 2023-03-17 | $581K | — | Filing → |